Catalyst Pharmaceuticals, Inc. financial data

Symbol
CPRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
355 Alhambra Circle, Suite 801, Coral Gables, FL
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Catalyst Pharmaceutical Partners, Inc. (to 5/12/2015), CATALYST PHARMACEUTICAL PARTNERS, INC. (to 5/12/2015)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 422 % -13.9%
Quick Ratio 20.5 % +23.7%
Debt-to-equity 17.3 % -21.1%
Return On Equity 14.3 % -60.4%
Return On Assets 12.2 % -58.9%
Operating Margin 19.8 % -56.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 119M shares +11.4%
Common Stock, Shares, Outstanding 119M shares +11.3%
Entity Public Float 1.34B USD +102%
Common Stock, Value, Issued 119K USD +11.2%
Weighted Average Number of Shares Outstanding, Basic 118M shares +11.2%
Weighted Average Number of Shares Outstanding, Diluted 125M shares +9.66%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 434M USD +43.4%
Research and Development Expense 91.2M USD +358%
Operating Income (Loss) 85.9M USD -37.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 93.6M USD -35.4%
Income Tax Expense (Benefit) 25.4M USD -13.2%
Net Income (Loss) Attributable to Parent 68.1M USD -41%
Earnings Per Share, Basic 0.58 USD/shares -47.3%
Earnings Per Share, Diluted 0.56 USD/shares -45.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 376M USD +110%
Accounts Receivable, after Allowance for Credit Loss, Current 57.2M USD +33.6%
Inventory, Net 18M USD +67.6%
Assets, Current 474M USD +96.9%
Deferred Income Tax Assets, Net 39.9M USD +69.8%
Property, Plant and Equipment, Net 1.23M USD +2%
Operating Lease, Right-of-Use Asset 2.37M USD -10.2%
Assets 706M USD +59.1%
Accounts Payable, Current 7.12M USD +61%
Employee-related Liabilities, Current 7.3M USD +67.8%
Accrued Liabilities, Current 85.2M USD +77.2%
Liabilities, Current 92.3M USD +75.8%
Operating Lease, Liability, Noncurrent 2.99M USD -11.4%
Other Liabilities, Noncurrent 2.4M USD -81.2%
Liabilities 97.7M USD +42.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) 185M USD +58.2%
Stockholders' Equity Attributable to Parent 609M USD +62.2%
Liabilities and Equity 706M USD +59.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 31.9M USD +164%
Net Cash Provided by (Used in) Financing Activities 141M USD +94564%
Net Cash Provided by (Used in) Investing Activities -199K USD +99.9%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 119M shares +11.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 376M USD +110%
Interest Paid, Excluding Capitalized Interest, Operating Activities 65K USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 38.3M USD +91.4%
Operating Lease, Liability 3.38M USD -9.47%
Depreciation 86K USD +24.6%
Payments to Acquire Property, Plant, and Equipment 199K USD +169%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 68.1M USD -41.1%
Lessee, Operating Lease, Liability, to be Paid 3.95M USD -11.5%
Operating Lease, Liability, Current 385K USD +9.07%
Lessee, Operating Lease, Liability, to be Paid, Year Two 553K USD +2.98%
Lessee, Operating Lease, Liability, to be Paid, Year One 537K USD +2.87%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 573K USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Three 570K USD +3.07%
Deferred Tax Assets, Operating Loss Carryforwards 0 USD -100%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 587K USD +2.98%
Operating Lease, Payments 129K USD +3.2%
Additional Paid in Capital 423M USD +64%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 9.34M USD +43.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%